{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:47:15Z","timestamp":1791362835254,"version":"4.3.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00467-025-06657-w","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T03:12:10Z","timestamp":1738206730000},"page":"1965-1973","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical applicability of 2023 International Pediatric Nephrology Association recommended limited therapeutic drug monitoring formulae to assess mycophenolic acid exposure"],"prefix":"10.1007","volume":"40","author":[{"given":"Ajay P.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamim","family":"Norozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alethia Paulina Monserrat","family":"Guzm\u00e1n-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Filler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"6657_CR1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00431-017-2891-2","volume":"176","author":"G Deschenes","year":"2017","unstructured":"Deschenes G, Vivarelli M, Peruzzi L (2017) Variability of diagnostic criteria and treatment of idiopathic nephrotic syndrome across European countries. Eur J Pediatr 176:647\u2013654","journal-title":"Eur J Pediatr"},{"key":"6657_CR2","doi-asserted-by":"crossref","unstructured":"Trautmann A, Boyer O, Hodson E, Bagga A, Gipson DS, Samuel S, Wetzels J, Alhasan K, Banerjee S, Bhimma R, Bonilla-Felix M, Cano F, Christian M, Hahn D, Kang HG, Nakanishi K, Safouh H, Trachtman H, Xu H, Cook W, Vivarelli M, Haffner D; International Pediatric Nephrology Association (2023) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 38:877-919","DOI":"10.1007\/s00467-022-05739-3"},{"key":"6657_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00431-012-1913-3","volume":"172","author":"S Fujinaga","year":"2013","unstructured":"Fujinaga S, Someya T, Watanabe T, Ito A, Ohtomo Y, Shimizu T, Kaneko K (2013) Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab. Eur J Pediatr 172:513\u2013518","journal-title":"Eur J Pediatr"},{"key":"6657_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/nep.12537","volume":"21","author":"J Wang","year":"2016","unstructured":"Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L (2016) Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome. Nephrology (Carlton) 21:21\u201327","journal-title":"Nephrology (Carlton)"},{"key":"6657_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10157-016-1266-8","volume":"21","author":"B Basu","year":"2017","unstructured":"Basu B, Babu BG, Mahapatra TK (2017) Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children. Clin Exp Nephrol 21:143\u2013151","journal-title":"Clin Exp Nephrol"},{"key":"6657_CR6","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s00467-008-0899-6","volume":"23","author":"EM Dorresteijn","year":"2008","unstructured":"Dorresteijn EM, Kist-van Holthe JE, Levtchenko EN, Nauta J, Hop WC, van der Heijden AJ (2008) Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome. Pediatr Nephrol 23:2013\u20132020","journal-title":"Pediatr Nephrol"},{"key":"6657_CR7","doi-asserted-by":"crossref","unstructured":"Gellermann J, Weber L, Pape L, Tonshoff B, Hoyer P, Querfeld U; Gesellschaft f\u00fcr P\u00e4diatrische Nephrologie (GPN) (2013) Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol 24:1689-1697","DOI":"10.1681\/ASN.2012121200"},{"key":"6657_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.742444","volume":"12","author":"N Nourbakhsh","year":"2021","unstructured":"Nourbakhsh N, Ekberg J, Skov K, Peters CD, Ozbay A, Lindner P, Buus NH (2021) Effects of corticosteroid treatment on mycophenolic acid exposure in renal transplant patients-results from the SAILOR study. Front Pharmacol 12:742444","journal-title":"Front Pharmacol"},{"key":"6657_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00467-023-05974-2","volume":"39","author":"FF Lai","year":"2024","unstructured":"Lai FF, Chan EY, Tullus K, Ma AL (2024) Therapeutic drug monitoring in childhood idiopathic nephrotic syndrome: a state of the art review. Pediatr Nephrol 39:85\u2013103","journal-title":"Pediatr Nephrol"},{"key":"6657_CR10","first-page":"268","volume":"72","author":"S Fujinaga","year":"2009","unstructured":"Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, Kaneko K, Shimizu T (2009) Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center. Clin Nephrol 72:268\u2013273","journal-title":"Clin Nephrol"},{"key":"6657_CR11","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.2215\/CJN.00320116","volume":"11","author":"S Tellier","year":"2016","unstructured":"Tellier S, Dallocchio A, Guigonis V, Saint-Marcoux F, Llanas B, Ichay L, Bandin F, Godron A, Morin D, Brochard K, Gandia P, Bouchet S, Marquet P, Decramer S, Harambat J (2016) Mycophenolic acid pharmacokinetics and relapse in children with steroid-dependent idiopathic nephrotic syndrome. Clin J Am Soc Nephrol 11:1777\u20131782","journal-title":"Clin J Am Soc Nephrol"},{"key":"6657_CR12","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/FTD.0000000000000671","volume":"41","author":"MR Benz","year":"2019","unstructured":"Benz MR, Ehren R, Kleinert D, Muller C, Gellermann J, Fehrenbach H, Schmidt H, Weber LT (2019) Generation and validation of a limited sampling strategy to monitor mycophenolic acid exposure in children with nephrotic syndrome. Ther Drug Monit 41:696\u2013702","journal-title":"Ther Drug Monit"},{"key":"6657_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1365-2710.2008.00973.x","volume":"34","author":"T Pawinski","year":"2009","unstructured":"Pawinski T, Kunicki PK, Sobieszczanska-Malek M, Gralak B, Szlaska I (2009) A limited sampling strategy for estimating mycophenolic acid area under the curve in adult heart transplant patients treated with concomitant cyclosporine. J Clin Pharm Ther 34:89\u2013101","journal-title":"J Clin Pharm Ther"},{"key":"6657_CR14","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.kint.2021.06.036","volume":"100","author":"T van Gelder","year":"2021","unstructured":"van Gelder T (2021) How cyclosporine reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do not. Kidney Int 100:1185\u20131189","journal-title":"Kidney Int"},{"key":"6657_CR15","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.3390\/molecules26123723","volume":"26","author":"J Sobiak","year":"2021","unstructured":"Sobiak J, Resztak M, Chrzanowska M, Zachwieja J, Ostalska-Nowicka D (2021) The evaluation of multiple linear regression-based limited sampling strategies for mycophenolic acid in children with nephrotic syndrome. Molecules 26:3723","journal-title":"Molecules"},{"key":"6657_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1034\/j.1399-3046.2002.02039.x","volume":"6","author":"G Filler","year":"2002","unstructured":"Filler G, Feber J, Lepage N, Weiler G, Mai I (2002) Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children. Pediatr Transplant 6:411\u2013418","journal-title":"Pediatr Transplant"},{"key":"6657_CR17","first-page":"120","volume":"17","author":"G Filler","year":"2004","unstructured":"Filler G (2004) Abbreviated mycophenolic acid AUC from C0, C1, C2, and C4 is preferable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy. Transpl Int 17:120\u2013125","journal-title":"Transpl Int"},{"key":"6657_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40780-017-0086-7","volume":"3","author":"T Enokiya","year":"2017","unstructured":"Enokiya T, Nishikawa K, Muraki Y, Iwamoto T, Kanda H, Sugimura Y, Okuda M (2017) Usefulness of limited sampling strategy for mycophenolic acid area under the curve considering postoperative days in living-donor renal transplant recipients with concomitant prolonged-release tacrolimus. J Pharm Health Care Sci 3:17","journal-title":"J Pharm Health Care Sci"},{"key":"6657_CR19","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00431-021-04294-7","volume":"181","author":"T Nishimura","year":"2022","unstructured":"Nishimura T, Uemura O, Hibino S, Tanaka K, Kitagata R, Yuzawa S, Kasagi T, Fujita N (2022) Serum albumin level is associated with mycophenolic acid concentration in children with idiopathic nephrotic syndrome. Eur J Pediatr 181:1159\u20131165","journal-title":"Eur J Pediatr"},{"key":"6657_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","volume":"41","author":"M Brunet","year":"2019","unstructured":"Brunet M, van Gelder T, Asberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millan O, Mizuno T, Moes DAR, Monchaud C, Noceti O, Pawinski T, Picard N, van Schaik R, Sommerer C, Vethe NT, de Winter B, Christians U, Bergan S (2019) Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report. Ther Drug Monit 41:261\u2013307","journal-title":"Ther Drug Monit"},{"key":"6657_CR21","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/S0041-1345(98)00201-2","volume":"30","author":"E Schutz","year":"1998","unstructured":"Schutz E, Shipkova M, Armstrong VW, Niedmann PD, Weber L, Tonshoff B, Pethig K, Wahlers T, Braun F, Ringe B, Oellerich M (1998) Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites. Transplant Proc 30:1185\u20131187","journal-title":"Transplant Proc"},{"key":"6657_CR22","doi-asserted-by":"crossref","unstructured":"Hummel M, Yonan N, Ross H, Miller LW, Sechaud R, Balez S, Koelle EU, Gerosa G; ERL 2401 Study Group (2007) Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients. Clin Transplant 21:18-23","DOI":"10.1111\/j.1399-0012.2006.00569.x"},{"key":"6657_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/FTD.0000000000000151","volume":"37","author":"PK Kunicki","year":"2015","unstructured":"Kunicki PK, Pawinski T, Boczek A, Was J, Bodnar-Broniarczyk M (2015) A comparison of the immunochemical methods, PETINIA and EMIT, with that of HPLC-UV for the routine monitoring of mycophenolic acid in heart transplant patients. Ther Drug Monit 37:311\u2013318","journal-title":"Ther Drug Monit"},{"key":"6657_CR24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5414\/CN109583","volume":"91","author":"A Kirpalani","year":"2019","unstructured":"Kirpalani A, Rothfels L, Sharma AP, Cuellar CR, Filler G (2019) Nephrotic state substantially enhances apparent mycophenolic acid clearance. Clin Nephrol 91:162\u2013171","journal-title":"Clin Nephrol"},{"key":"6657_CR25","doi-asserted-by":"publisher","first-page":"506","DOI":"10.5414\/CP203487","volume":"57","author":"B Reigner","year":"2019","unstructured":"Reigner B, Grange S, Bentley D, Banken L, Abt M, Hughes R, Scheubel E, Guentert TW (2019) Generics in transplantation medicine: Randomized comparison of innovator and substitution products containing mycophenolate mofetil. Int J Clin Pharmacol Ther 57:506\u2013519","journal-title":"Int J Clin Pharmacol Ther"},{"key":"6657_CR26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1681\/ASN.V133759","volume":"13","author":"LT Weber","year":"2002","unstructured":"Weber LT, Shipkova M, Armstrong VW, Wagner N, Schutz E, Mehls O, Zimmerhackl LB, Oellerich M, Tonshoff B (2002) The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy. J Am Soc Nephrol 13:759\u2013768","journal-title":"J Am Soc Nephrol"},{"key":"6657_CR27","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/FTD.0b013e3181c01d07","volume":"31","author":"F Parant","year":"2009","unstructured":"Parant F, Rivet C, Boulieu R, Gagnieu MC, Dumortier J, Boillot O, Lachaux A (2009) Age-related variability of mycophenolate mofetil exposure in stable pediatric liver transplant recipients and influences of donor characteristics. Ther Drug Monit 31:727\u2013733","journal-title":"Ther Drug Monit"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06657-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-06657-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06657-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T05:55:30Z","timestamp":1745560530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-06657-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["6657"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-06657-w","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}